about
Controlled release systems containing solid dispersions: strategies and mechanismsDrug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.New investigation of distribution imaging and content uniformity of very low dose drugs using hot-melt extrusion method.The effects of screw configuration and polymeric carriers on hot-melt extruded taste-masked formulations incorporated into orally disintegrating tablets.Mefenamic acid taste-masked oral disintegrating tablets with enhanced solubility via molecular interaction produced by hot melt extrusion technologyStability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.Development of taste masked caffeine citrate formulations utilizing hot melt extrusion technology and in vitro-in vivo evaluationsInfluence of Molecular Weight of Carriers and Processing Parameters on the Extrudability, Drug Release, and Stability of Fenofibrate Formulations Processed by Hot-Melt ExtrusionDevelopment of an antifungal denture adhesive film for oral candidiasis utilizing hot melt extrusion technology.Physicochemical principles of controlled release solid dispersion containing a poorly water-soluble drug.Physical properties and in vivo bioavailability in human volunteers of isradipine using controlled release matrix tablet containing self-emulsifying solid dispersion.Dissolution-enhancing mechanism of alkalizers in poloxamer-based solid dispersions and physical mixtures containing poorly water-soluble valsartan.Preparation and characterization of pH-independent sustained release tablet containing solid dispersion granules of a poorly water-soluble drug.Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storageEffects of solvents and crystallization conditions on the polymorphic behaviors and dissolution rates of valsartanPreparation of Sustained Release Tablet with Minimized Usage of Glyceryl Behenate Using Post-Heating Method
P50
Q24301733-FA00ED49-AF5F-45D1-9FA4-453709E819B2Q31123176-F1E7BB2F-E4D8-441A-9B8C-26AC6E774A38Q35025882-44F5BDBE-E9EC-4127-872E-4B5516DF9079Q35078360-DE6ED03B-1FF3-4B99-AB7E-D0033BA30EACQ35505617-D3E5F9B9-459A-4B38-9AAC-C94A53F77B9EQ35868365-7BAF0A30-CADF-47DE-AFD8-EE69BB940FF9Q35977237-D5B305DD-57E5-418B-AF3E-826432D3C7C8Q36343942-F1241448-F785-4987-8C6C-ED5D159CBEEDQ42276006-1698CADC-0685-4E41-BEDA-DEA667D03A88Q42716862-23D1619D-2FAB-4C86-BE19-0E9E4FC9EC56Q43441213-FD69BD25-C094-4056-B716-274D4E705C38Q43856913-C27C76F5-E519-4C42-A29B-6740B114E3E7Q53421922-6D6BDDF8-6F6C-4E05-BD07-8BF655736EC8Q84084335-3EEA3603-4928-4BCF-B6F1-A91D342A04ADQ84733129-F6B0BE71-9819-4B42-B8B4-DA70F3F7D816Q90864298-8BEC0FE7-1FDC-471D-9656-243ED3387742
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jun-bom Park
@ast
Jun-bom Park
@en
Jun-bom Park
@es
Jun-bom Park
@nl
Jun-bom Park
@sl
type
label
Jun-bom Park
@ast
Jun-bom Park
@en
Jun-bom Park
@es
Jun-bom Park
@nl
Jun-bom Park
@sl
prefLabel
Jun-bom Park
@ast
Jun-bom Park
@en
Jun-bom Park
@es
Jun-bom Park
@nl
Jun-bom Park
@sl
P106
P1153
36673633500
P31
P496
0000-0001-6193-0023